Bio Plus Co., Ltd (KOSDAQ:099430)
4,575.00
-120.00 (-2.56%)
Jun 10, 2026, 3:30 PM KST
Bio Plus Revenue
Bio Plus had revenue of 26.51B KRW in the quarter ending March 31, 2026, with 15.35% growth. This brings the company's revenue in the last twelve months to 94.42B, up 18.36% year-over-year. In the year 2025, Bio Plus had annual revenue of 90.90B with 36.87% growth.
Revenue (ttm)
94.42B
Revenue Growth
+18.36%
P/S Ratio
2.98
Revenue / Employee
n/a
Employees
n/a
Market Cap
281.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 90.90B | 24.49B | 36.87% |
| Dec 31, 2024 | 66.41B | 1.37B | 2.10% |
| Dec 31, 2023 | 65.04B | 8.32B | 14.68% |
| Dec 31, 2022 | 56.72B | 19.30B | 51.58% |
| Dec 31, 2021 | 37.42B | 13.05B | 53.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| i-SENS | 314.31B |
| InBody Co.,Ltd | 246.81B |
| WON TECH | 159.67B |
| DRTECH | 122.78B |
| Osang Healthcare Co.,Ltd | 119.38B |
| LabGenomics | 84.19B |
| SEERS | 76.63B |
| Curexo | 70.92B |